310 related articles for article (PubMed ID: 1662929)
1. Cytotoxicity and differentiation-inducing activity of phenothiazine and benzo[a]phenothiazine derivatives.
Motohashi N; Sakagami H; Kamata K; Yamamoto Y
Anticancer Res; 1991; 11(5):1933-7. PubMed ID: 1662929
[TBL] [Abstract][Full Text] [Related]
2. Radical intensity and differentiation-inducing activity of benzo[a]phenothiazines and phenothiazines.
Satoh K; Sakagami H; Kurihara T; Motohashi N
Anticancer Res; 1997; 17(4A):2465-9. PubMed ID: 9252664
[TBL] [Abstract][Full Text] [Related]
3. Induction of DNA fragmentation in human myelogenous leukaemic cell lines by phenothiazine-related compounds.
Sakagami H; Takahashi H; Yoshida H; Yamamura M; Fukuchi K; Gomi K; Motohashi N; Takeda M
Anticancer Res; 1995; 15(6B):2533-40. PubMed ID: 8669819
[TBL] [Abstract][Full Text] [Related]
4. Relationship between tumor (T) antigen expression and substituent effects on benzo [a] phenothiazines.
Pusztai R; Motohashi N; Párkányi C; Aaron JJ; Rao BK; Molnár J
Anticancer Res; 1996; 16(5A):2961-4. PubMed ID: 8917413
[TBL] [Abstract][Full Text] [Related]
5. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
[TBL] [Abstract][Full Text] [Related]
6. Relationship between biological activity and dipole moment in benzo[a]phenothiazines.
Motohashi N; Kurihara T; Yamanaka W; Satoh K; Sakagami H; Molnár J
Anticancer Res; 1997; 17(5A):3431-5. PubMed ID: 9413182
[TBL] [Abstract][Full Text] [Related]
7. Radical modulation activity of benzo[a]phenothiazine.
Satoh K; Sakagami H; Motohashi N
Anticancer Res; 1997; 17(4A):2539-43. PubMed ID: 9252677
[TBL] [Abstract][Full Text] [Related]
8. Effect of benzo[a]phenothiazines on natural killer cell activity of human peripheral blood mononuclear cells.
Petri IB; Szekeres E; Berek I; Molnár J; Sakagami H; Motohashi N
Anticancer Res; 1993; 13(6A):2273-5. PubMed ID: 8297145
[TBL] [Abstract][Full Text] [Related]
9. The primary in vitro antitumor screening of "half-mustard type" phenothiazines.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Nacsa J; Molnár J
Anticancer Res; 1997; 17(5A):3409-23. PubMed ID: 9413180
[TBL] [Abstract][Full Text] [Related]
10. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia.
Zhelev Z; Ohba H; Bakalova R; Hadjimitova V; Ishikawa M; Shinohara Y; Baba Y
Cancer Chemother Pharmacol; 2004 Mar; 53(3):267-75. PubMed ID: 14663628
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of phenothiazines, benzo[a]phenothiazines and benz[c]acridines.
Motohashi N; Sakagami H; Kurihara T; Ferenczy L; Csuri K; Molnar J
Anticancer Res; 1992; 12(4):1207-10. PubMed ID: 1503410
[TBL] [Abstract][Full Text] [Related]
12. Influence of benzo[a]phenothiazines on the element content of two tobacco tissue cultures differing in hormone requirement.
Szabó M; Csiszár J; Rausch H; Molnár J; Motohashi N
Anticancer Res; 1997; 17(3C):2049-56. PubMed ID: 9216663
[TBL] [Abstract][Full Text] [Related]
13. Diverse biological activities displayed by phenothiazines, benzo[a]phenothiazines and benz[c]acridins (review).
Molnár J; Sakagami H; Motohashi N
Anticancer Res; 1993; 13(4):1019-25. PubMed ID: 8352520
[TBL] [Abstract][Full Text] [Related]
14. Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines.
Kamijo R; Takeda K; Nagumo M; Konno K
J Immunol; 1990 Feb; 144(4):1311-6. PubMed ID: 2105994
[TBL] [Abstract][Full Text] [Related]
15. Combination of benzo[a]phenothiazines with acyclovir against herpes simplex virus.
Mucsi I; Molnár J; Motohashi N
Int J Antimicrob Agents; 2001 Jul; 18(1):67-72. PubMed ID: 11463529
[TBL] [Abstract][Full Text] [Related]
16. Antitumor potential and possible targets of phenothiazine-related compounds.
Motohashi N; Kawase M; Saito S; Sakagami H
Curr Drug Targets; 2000 Nov; 1(3):237-45. PubMed ID: 11465073
[TBL] [Abstract][Full Text] [Related]
17. The in vitro antitumor assay of "half-mustard type" phenothiazines in screens of AIDS-related leukemia and lymphomas.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Molnár J
Anticancer Res; 1997; 17(5A):3425-9. PubMed ID: 9413181
[TBL] [Abstract][Full Text] [Related]
18. Antimutagenicity of benzo[a]phenothiazines in chemically induced mutagenesis.
Tanaka M; Wayda K; Molnár J; Párkányi C; Aaron JJ; Motohashi N
Anticancer Res; 1997; 17(2A):839-42. PubMed ID: 9137417
[TBL] [Abstract][Full Text] [Related]
19. Preliminary studies on phenothiazine-mediated reversal of multidrug resistance in mouse lymphoma and COLO 320 cells.
Pajak B; Molnar J; Engi H; Orzechowski A
In Vivo; 2005; 19(6):1101-4. PubMed ID: 16277030
[TBL] [Abstract][Full Text] [Related]
20. Effects of two benzo[a]phenothiazines on multi-drug resistance (mdr) and tumor antigen expression.
Molnár J; Pusztai R; Hevér A; Nagy S; Motohashi N
Anticancer Res; 1995; 15(5B):2013-6. PubMed ID: 8572594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
